Gentex Q3 sales up 8% to $655.2 million on VOXX; net income falls to $101.0 million
Gentex reported third-quarter 2025 results on October 24, 2025. Consolidated net sales rose 8% to $655.2 million, including $84.9 million from the VOXX acquisition, while core Gentex sales fell 6% to $570.3 million. Net income attributable to Gentex fell to $101.0 million, or $0.46 per diluted share, from $122.5 million a year earlier, when a $14.9 million one-time gain on the original VOXX investment boosted results. The company also changed its 2025 guidance, narrowing full-year consolidated revenue to $2.50 to $2.60 billion.
Key points
- Consolidated net sales of $655.2 million vs. $608.5 million in Q3 2024; core Gentex net sales of $570.3 million, down 6%
- Net income attributable to Gentex of $101.0 million vs. $122.5 million; diluted EPS of $0.46 vs. $0.53, with the prior-year period including a $14.9 million VOXX investment gain
- Core Gentex gross margin of 34.9%, up 140 basis points; tariffs reduced margins by about 90 basis points
- 2025 consolidated revenue guidance now $2.50 to $2.60 billion (previously $2.44 to $2.61 billion); Gentex China revenue guidance raised to $135 to $145 million
The filing
Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 24, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.